Macquarie Group’s Innovid Corp. CTV Stock Holding History

Macquarie Group’s Portfolio CTV Stock Details CTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,846	Closed	-$12	–	2183
2024 Q1	$12	Buy	+4,846	New	+$8.38K	﹤0.01%	1720

Other funds holding CTV

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group's CTV Position: Q2 2024 in Review

Macquarie Group sold out of Innovid Corp. (CTV) in Q2 2024, closing a stake of 4,846 shares — an estimated $12 sold.

Macquarie Group first reported a position in CTV in Q1 2024 and held it in 1 quarter. The position peaked at $12 in Q1 2024. 74 funds tracked by Wall St. Rank hold CTV as of Q2 2024.

Macquarie Group reported no remaining Innovid Corp. position as of Q2 2024 after selling out during the quarter.
Macquarie Group sold 4,846 Innovid Corp. shares in Q2 2024, an estimated $12.
Macquarie Group first reported a position in Innovid Corp. in Q1 2024 and held it in 1 quarter.
Macquarie Group's Innovid Corp. position peaked at $12 in Q1 2024.
74 funds tracked by Wall St. Rank held Innovid Corp. as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.